课题基金 / 基金详情

Nanosilver antimicrobial resistance in target pathogens

Nanosilver antimicrobial resistance in target pathogens
目标病原体中的纳米银抗菌药物耐药性
批准号:
DP180100474
负责人:
A/Prof Cindy Gunawan
金额:
$26.1万
依托单位国家:
澳大利亚
项目类别:
Discovery Projects
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-04-01 至 2021-12-31

项目摘要

项目成果

A/Prof Cindy Gunawan的其他基金

相似基金

相关文献

中文摘要
翻译
该项目旨在阐明细菌对抗菌纳米银的耐药性的重要现象,纳米银是目前最发达和商业化的纳米技术产品之一。综合研究方法包括同时鉴定细菌中纳米银毒性的起源和途径以及细菌防御毒性的出现和机制。所产生的知识是形成用于新型纳米银工程的基础模板,其具有较少的抗性发展趋势,并有助于追踪抗性及其在微生物中的传播。这些知识对更好地管理纳米银的使用,包括其处置具有深远的影响。
英文摘要
This project aims to elucidate the important phenomena of bacterial resistance to antimicrobial nanosilver, currently one of the most developed and commercialised products of nanotechnology. The integrated research approach comprises of concurrent identification of the origins and routes of nanosilver toxicity in bacteria and the arising emergence and mechanisms of bacterial defence to the toxicity. The generated knowledge is to form a base template for novel nanosilver engineering with less tendency for resistance development and to facilitate tracking of resistance and its spread amongst microorganisms. The knowledge has far-reaching implications on the better governance of nanosilver use, including its disposal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Molecular Basis of Nanoparticle Resistance in Mixed-Species Biofilm
  • 批准号:
    DP220101819
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $26.94万
  • 财政年份:
    2022
  • 负责人:
    A/Prof Cindy Gunawan
  • 依托单位:
海外基金